We previously reported MELK as a desirable therapeutic target to treat many types of cancer because of its indispensable roles in cancer cell survival and restricted expression in cancer cells [3]; MELK is highly expressed in a great majority of breast cancer and glioblastoma, but its expression was hardly detectable in normal adult tissues except in the testis [3, 4]. The gene discussed is MELK; the disease is breast cancer.